Trial Profile
A Study to Evaluate the Real-World Treatment Patterns and Medical Costs in Metastatic Breast Cancer Patients Treated with Trastuzumab Emtansine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2016
Price :
$35
*
At a glance
- Drugs Trastuzumab emtansine (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 05 Feb 2016 New trial record
- 12 Dec 2015 Results presented at the 38th Annual San Antonio Breast Cancer Symposium